David Fox
David Fox's interests include small molecule (asymmetric) synthesis and applications of these molecules, mainly in medicinal chemistry / drug discovery and scale-up and GMP process development. Specialist areas include drug molecule design, fast and direct synthesis, and synthetic route development for lead molecules.
As well as an academic role at 91福利, David Fox was a lead chemist at Functional Therapeutics (2006-12) and at Epsilon3Bio (2011-2017) and is now a consultant at RxCelerate Ltd.